| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,111 | 25,189 | 20,273 | 20,365 | | Cost of Revenue | 4,931 | 5,332 | 5,606 | 5,964 | | | Gross Profit |
-
| 19,857 | 14,667 | 14,401 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,616 | 9,420 | 8,464 | 7,651 | | Non Recurring |
-
| 7,243 | 1,208 | 2,735 | | Others | 3,585 | 24,748 | 2,648 | 5,660 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (21,554) | 2,347 | (1,645) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (13,021) | (21,554) | 2,347 | (1,645) | | Interest Expense | 996 | 1,000 | 1,038 | 1,196 | | Income Before Tax | (14,017) | (22,554) | 1,309 | (2,841) | | Income Tax Expense | (5,605) | (6,339) | 244 | (1,282) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,412) | (16,215) | 1,065 | (1,559) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,412) | (16,215) | 1,065 | (1,559) | | Preferred Stock And Other Adjustments | (467) | (875) |
-
| (51) | | | Net Income Applicable To Common Shares | ($8,879) | ($17,090) | $1,065 | ($1,610) |
|
0.14% Nasdaq 
0.27%
Income Statement
